e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Post-transplant complications: from pathogenesis to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Non-tuberculous mycobacterium infection in lung transplant recipients
H. E. Riera Ave, C. Bravo, B. Sáez, T. Tórtola, F. Ruiz, C. Berastegui, M. Lopez Meseguer, V. Monforte, A. Román (Barcelona, Madrid, Spain)
Source:
International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Session:
Post-transplant complications: from pathogenesis to treatment
Session type:
Poster Discussion
Number:
3313
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. E. Riera Ave, C. Bravo, B. Sáez, T. Tórtola, F. Ruiz, C. Berastegui, M. Lopez Meseguer, V. Monforte, A. Román (Barcelona, Madrid, Spain). Non-tuberculous mycobacterium infection in lung transplant recipients. Eur Respir J 2014; 44: Suppl. 58, 3313
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Nocardia infections in lung transplant recipients (LxTR)
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Nocardia infections after lung transplantation: A case series
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Hypogammaglobulinemia in lung transplant candidates
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
First reported case of disseminated
talaromyces marneffei
infection in a lung transplant patient
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Isolation of stenotrophomonas maltophilia in lung transplant recipients: effects of treatment on prevalence and outcome
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
Severe infection due to
corynebacterium striatum
or
amycolatum
in 6 lung transplanted patients
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Early and late viral infections after lung transplantation
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015
Fungal re-colonization in cystic fibrosis or bronchiectasis patients after lung transplantation: Incidence, time of onset and related-factors
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Posaconazole levels in the bronchoalveolar lavage from lung transplant recipients
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
A case series of fidaxomicin for treatment of Clostridium difficile infection (CDI) in lung transplant (LTx) recipients
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Azole plasma concentrations in lung transplant recipients
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Lung transplantation for silicosis, report of 17 patients
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Malignant tumours in lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Carbapenem-resistant Klebsiella pneumoniae in lung transplant recipients: A case series
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
Osteoporosis in lung transplant patients
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Pulmonary
cladophialophora boppii
infection in a lung transplant recipient
Source: Eur Respir J 2006; 28: Suppl. 50, 777s
Year: 2006
Viral infection land lung function decline following lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Cytomegalovirus as predisposing agent to respiratory infections in heart transplant patients
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept